首页> 美国卫生研究院文献>Oncology Letters >Pathological complete response following neoadjuvant radiotherapy and intraperitoneal perfusion chemotherapy for recurrent colon carcinoma: A case report and literature review
【2h】

Pathological complete response following neoadjuvant radiotherapy and intraperitoneal perfusion chemotherapy for recurrent colon carcinoma: A case report and literature review

机译:新辅助放疗联合腹腔内灌注化疗治疗复发性结肠癌的病理完全缓解:一例报告并文献复习

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The present study reports the case of a 28-year-old male who was diagnosed with sigmoid colon carcinoma and exhibited local recurrence following radical surgery and 6 cycles of adjuvant chemotherapy. The primary surgery consisted of a partial sigmoidectomy and bladder repair. At 8 months post-chemotherapy, the patient was referred to Nanjing Drum Tower Hospital (Nanjing, China) due to local recurrence at the anastomotic site, which was confirmed by colonoscopy and total abdominal computed tomography. Synchronous intensity modulation radiation therapy and intraperitoneal (IP) perfusion chemotherapy with irinotecan (100 mg/m2) was administered. Following treatment, the object efficacy evaluation revealed a complete response and a second resection of the remaining sigmoid colon was performed. The post-operative results showed a pathological complete response. This case indicated that a combination of therapies, including radiotherapy, IP perfusion chemotherapy and surgery, may be beneficial and effective in patients with recurrent colon cancer.
机译:本研究报道了一例28岁的男性,该男性被诊断为乙状结肠癌,并在根治性手术和6周期辅助化疗后表现出局部复发。主要手术包括部分乙状结肠切除术和膀胱修复。化疗后8个月,患者由于吻合部位的局部复发而被转诊到南京鼓楼医院(中国南京),并通过结肠镜检查和总腹部CT证实。进行同步强度调制放射治疗和伊立替康(100 mg / m 2 )腹膜内灌注化疗。治疗后,目标疗效评估显示反应完全,对剩余的乙状结肠进行了第二次切除。术后结果显示病理完全缓解。该病例表明,包括放疗,IP灌注化疗和手术在内的多种疗法对复发性结肠癌患者可能是有益而有效的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号